[go: up one dir, main page]

MX2013011355A - Metodo de produccion de polipeptido recombinante. - Google Patents

Metodo de produccion de polipeptido recombinante.

Info

Publication number
MX2013011355A
MX2013011355A MX2013011355A MX2013011355A MX2013011355A MX 2013011355 A MX2013011355 A MX 2013011355A MX 2013011355 A MX2013011355 A MX 2013011355A MX 2013011355 A MX2013011355 A MX 2013011355A MX 2013011355 A MX2013011355 A MX 2013011355A
Authority
MX
Mexico
Prior art keywords
production method
recombinant polypeptide
polypeptide production
nfkbia
producing
Prior art date
Application number
MX2013011355A
Other languages
English (en)
Other versions
MX352229B (es
Inventor
Hisahiro Tabuchi
Tomoya Sugiyama
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of MX2013011355A publication Critical patent/MX2013011355A/es
Publication of MX352229B publication Critical patent/MX352229B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporciona un método capaz de producir una proteína de alto nivel usando una célula animal cultivada, que comprende una célula que expresa APES (secuencia mejoradora de producción de anticuerpos) y en la cual se ha introducido un ADN que codifica un polipéptido deseado, lo que produce el polipéptido deseado; APES contiene una secuencia de nucleótidos relacionada con NfkBia y tiene una función de disminuir la expresión intracelular de NfkBia.
MX2013011355A 2011-04-01 2012-03-30 Metodo de produccion de polipeptido recombinante. MX352229B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011082002 2011-04-01
PCT/JP2012/058577 WO2012137683A1 (ja) 2011-04-01 2012-03-30 組換えポリペプチドの製造方法

Publications (2)

Publication Number Publication Date
MX2013011355A true MX2013011355A (es) 2013-12-16
MX352229B MX352229B (es) 2017-11-15

Family

ID=46969084

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011355A MX352229B (es) 2011-04-01 2012-03-30 Metodo de produccion de polipeptido recombinante.

Country Status (15)

Country Link
US (2) US11028149B2 (es)
EP (1) EP2695947B1 (es)
JP (3) JP6182066B2 (es)
KR (1) KR101958033B1 (es)
CN (3) CN106995831A (es)
AU (2) AU2012239382B2 (es)
BR (1) BR112013024781B1 (es)
CA (1) CA2830013C (es)
DK (1) DK2695947T3 (es)
ES (1) ES2620306T3 (es)
MX (1) MX352229B (es)
RU (1) RU2628310C2 (es)
SG (1) SG194014A1 (es)
TW (2) TWI647309B (es)
WO (1) WO2012137683A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2309508T3 (es) * 2003-03-11 2008-12-16 Laboratoires Serono Sa Vectores de expresion que comprenden el promotor de mcmv-ie2.
CN112522353A (zh) * 2012-10-10 2021-03-19 中外制药株式会社 经修饰的宿主细胞的建立方法
US9647919B1 (en) * 2014-12-04 2017-05-09 Amazon Technologies Automated determination of maximum service throughput
CN107287178B (zh) * 2016-04-12 2019-10-29 中国科学院微生物研究所 Csad蛋白及其编码基因在抗流感病毒中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9222931D0 (en) 1992-11-02 1992-12-16 Sandoz Ltd Organic compounds
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
WO2002031114A2 (en) 2000-10-11 2002-04-18 Digital Gene Technologies, Inc. Gene expression modulated in ileitis
CA2388761A1 (en) * 2001-06-18 2002-12-18 Pfizer Inc. Wound healing biomarkers
EP1784501B1 (en) * 2004-05-14 2015-11-18 Rosetta Genomics Ltd VIRAL AND VIRUS ASSOCIATED MicroRNAS AND USES THEREOF
CA2544692C (en) 2004-07-09 2014-04-01 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
ES2931949T3 (es) * 2005-03-29 2023-01-05 Univ Pennsylvania Minoxidilo para generar nuevos folículos pilosos y tratar la calvicie
WO2007119774A1 (ja) * 2006-04-13 2007-10-25 Chugai Seiyaku Kabushiki Kaisha タウリントランスポーター遺伝子
HRP20120175T1 (hr) 2006-06-02 2012-03-31 Regeneron Pharmaceuticals Antitijela s visokim afinitetom za humani il-6 receptor
US20100233759A1 (en) 2007-03-15 2010-09-16 Chugai Seiyaku Kabushiki Kaisha Method for production of polypeptide
US8062864B2 (en) * 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
EP2186905B1 (en) * 2007-08-07 2016-07-13 Chugai Seiyaku Kabushiki Kaisha Method of producing heterogeneous protein
WO2009051109A1 (ja) * 2007-10-15 2009-04-23 Chugai Seiyaku Kabushiki Kaisha 異種タンパク質を高生産する細胞の作製方法
JP5337044B2 (ja) * 2007-10-24 2013-11-06 中外製薬株式会社 異種タンパク質製造のための細胞及びそれを用いた製造方法
WO2009094084A1 (en) * 2007-12-21 2009-07-30 Danisco Us Inc., Genencor Division Enhanced protein production in bacillus

Also Published As

Publication number Publication date
JP6444968B2 (ja) 2018-12-26
TWI647309B (zh) 2019-01-11
BR112013024781A2 (pt) 2018-06-05
US20210246193A1 (en) 2021-08-12
CN103459608B (zh) 2018-05-01
CA2830013A1 (en) 2012-10-11
KR20140015506A (ko) 2014-02-06
ES2620306T3 (es) 2017-06-28
US11905325B2 (en) 2024-02-20
TW201726729A (zh) 2017-08-01
CN108546295A (zh) 2018-09-18
CN108546295B (zh) 2022-08-09
RU2013148804A (ru) 2015-05-10
JP6626160B2 (ja) 2019-12-25
AU2016201744A1 (en) 2016-04-07
AU2016201744B2 (en) 2017-09-28
WO2012137683A1 (ja) 2012-10-11
DK2695947T3 (en) 2017-05-08
TWI674272B (zh) 2019-10-11
TW201303019A (zh) 2013-01-16
BR112013024781B1 (pt) 2021-09-08
US20140030758A1 (en) 2014-01-30
EP2695947A4 (en) 2014-10-29
US11028149B2 (en) 2021-06-08
KR101958033B1 (ko) 2019-03-13
EP2695947A1 (en) 2014-02-12
AU2012239382B2 (en) 2016-04-21
AU2012239382A1 (en) 2013-10-17
RU2628310C2 (ru) 2017-08-15
SG194014A1 (en) 2013-11-29
CA2830013C (en) 2020-01-07
EP2695947B1 (en) 2017-03-01
JP2018161146A (ja) 2018-10-18
JPWO2012137683A1 (ja) 2014-07-28
JP6182066B2 (ja) 2017-08-16
CN106995831A (zh) 2017-08-01
CN103459608A (zh) 2013-12-18
MX352229B (es) 2017-11-15
JP2017074065A (ja) 2017-04-20

Similar Documents

Publication Publication Date Title
IL201395A (en) Multi-clonal cell lines and methods for generating multi-clonal cell lines
MX2010001319A (es) Metodo para producir proteinas heterogeneas.
MY186219A (en) Production of proteins in glutamine-free cell culture media
IL222452B (en) A process for preparing a recombinant polypeptide by growing mammalian cells in a serum-free and protein-free cell culture medium
WO2008153029A1 (ja) 特異的遺伝子発現方法
MY181513A (en) Cell culture compositions and methods for polypeptide production
MX2012009175A (es) Metodos para identificar y aislar celulas que expresan un polipeptido.
MX2013014937A (es) Cultivo de celulas de mamifero.
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
MX340952B (es) Diferenciacion de celulas madre embrionarias humanas.
MX2010004397A (es) Celula para uso en la produccion de proteina exogena y proceso de produccion que utiliza la celula.
MX336473B (es) Ensayo mediante adcc nk facs tridimensional.
PH12014501019A1 (en) Kit comprising serum replacement and labile factors
MX352229B (es) Metodo de produccion de polipeptido recombinante.
EP4589002A3 (en) Use of monensin to regulate glycosylation of recombinant proteins
WO2012125626A3 (en) Decorin compositions and use thereof
ES2523016A1 (es) Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
SG11201806843UA (en) Method for producing activated hepatocyte growth factor (hgf)
GEP201606542B (en) Recombinant expression of soluble interferon
WO2013032999A8 (en) Polydnavirus vectors
MY170261A (en) Compositions and methods of producing enterokinase in yeast ian fotheringham and peter j. sheffield
AU2011301714B2 (en) Synthetic gene for expressing Sm-14 in Pichia pastoris, methods for producing and purifying Sm-14 and the use thereof as a vaccine and diagnostic medium
WO2013095014A8 (ko) 화합물 결합단백질 검출 방법
UA65507U (ru) Способ получения культивируемых лимбальных клеток

Legal Events

Date Code Title Description
FG Grant or registration